Rofecoxib 1 g | ≥98% LKT Laboratories, Inc. NSAID; COX-2 inhibitor. More Information Supplier Page × Rofecoxib
Rosiglitazone Maleate 5 g | ≥98% LKT Laboratories, Inc. Thiazolidinedione; PPARγ agonist. More Information Supplier Page × Rosiglitazone Maleate
Rosiglitazone Maleate 1 g | ≥98% LKT Laboratories, Inc. Thiazolidinedione; PPARγ agonist. More Information Supplier Page × Rosiglitazone Maleate
Rosiglitazone Maleate 500 mg | ≥98% LKT Laboratories, Inc. Thiazolidinedione; PPARγ agonist. More Information Supplier Page × Rosiglitazone Maleate
Rosiglitazone 5 g | ≥98% LKT Laboratories, Inc. Thiazolidinedione; PPARγ agonist. More Information Supplier Page × Rosiglitazone
Rosiglitazone 1 g | ≥98% LKT Laboratories, Inc. Thiazolidinedione; PPARγ agonist. More Information Supplier Page × Rosiglitazone
Pantoprazole Sodium Sesquihydrate 25 g | ≥98% LKT Laboratories, Inc. H+/K+ ATPase and ROCK-2 inhibitor. More Information Supplier Page × Pantoprazole Sodium Sesquihydrate
Pantoprazole Sodium Sesquihydrate 5 g | ≥98% LKT Laboratories, Inc. H+/K+ ATPase and ROCK-2 inhibitor. More Information Supplier Page × Pantoprazole Sodium Sesquihydrate
Pantoprazole Sodium Sesquihydrate 1 g | ≥98% LKT Laboratories, Inc. H+/K+ ATPase and ROCK-2 inhibitor. More Information Supplier Page × Pantoprazole Sodium Sesquihydrate
β-Rubromycin 5 mg | ≥98% LKT Laboratories, Inc. Quinolone; telomerase and HIV-1 reverse transcriptase inhibitor. More Information Supplier Page × β-Rubromycin
